Xcout Intel
Neogap
Neogap Therapeutics is a privately held clinical-stage biopharmaceutical company founded in 2016 and located at the Cancer Center Karolinska in Stockholm, Sweden. The company focuses on immuno-oncology and is developing personalized therapies for cancer treatment.
Subscribe to see Neogap’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Neogap at a glance
Neogap is a biotechnology company headquartered in Sweden. Its most recent funding round raised $9.2M in February 2026. Xcout tracks 9 named people at Neogap, including Samuel Svensson (CEO).
Neogap leadership
- Samuel SvenssonCEO
- Andrea SalménCOO
- Lars-Erik AnderssonActing CFO
- Guro GafvelinCTO
- Johan LundChairman of the board MD, PhD
- Hans GrönlundCSO and founder
3 more named people on record for Neogap, with roles, board committees and tenure — see the full roster →
Neogap funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $9.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Neogap competitors
A few of Neogap's closest competitors — see the full list of competitors and alternatives →
Immatics is a biopharmaceutical company that develops T cell-based immunotherapies and bispecific product candidates to treat various types of cancer. The company focuses on precision targeting of the PRAME protein expressed in multiple solid tumors, serving cancer patients with high unmet medical needs.
Anocca is a fully integrated biopharmaceutical company founded in 2014 and headquartered in Södertälje, Sweden. The company focuses on building biotechnologies, processes, and infrastructure to decode T-cell immunity and develop new forms of engineered immunity.
OneChain Immunotherapeutics is a biotechnology company based in Barcelona focused on the development of CAR-T cell therapies and in vivo platforms for cancer immunotherapy.
Tiankeya (also known as Beijing TCR Cure Biopharma Technology Co., Ltd.) is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in China, with operations in China and the United States. The company focuses on the innovation, development, and clinical translation of engineered T cell and immune cell therapies to treat cancer and solid tumors.
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Get Neogap's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Neogap in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access